Delivery Order SPE2DB20D2104-SPE2DB25FMWHL
- Not listed
- The Defense Logistics Agency awarded a $2,342.93 delivery order to AmerisourceBergen Drug Corp for 180 tablets of Entresto 24 mg-26 mg on July 24, 2025, with completion scheduled for July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count) valued at $6,250.36. This firm fixed-price delivery order, with an ultimate completion date of July 10, 2025, will be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award utilized no set-aside designation and was competitively awarded under open competition. This delivery order falls under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count) valued at $3,510.76. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical supply transaction, which will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $6,011.74 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents...
- The Defense Logistics Agency awarded a delivery order valued at $3,365.77 to AmerisourceBergen Drug Corp for 180 tablets of Entresto 24 mg-26 mg on July 14, 2025, with an ultimate completion date of July 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The award was placed of performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,134.39 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets in a quantity of 60 units. This competitive award, executed on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,030.74 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Entresto 24 mg-26 mg on May 2, 2025, with an ultimate completion date of May 5, 2025. This competitive award, issued without set-aside designation, utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $9,378.51 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 17, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWHLDelivery Order
The Defense Logistics Agency awarded a $3,290.71 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). This delivery order is structured as a firm fixed price contract with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and federal healthcare systems. Entresto, a cardiac medication, aligns with the company's extensive portfolio of pharmaceuticals delivered across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 7/23/25 |